Hyperintense Vessels on Acute Stroke Fluid-Attenuated Inversion Recovery Imaging Associations With Clinical and Other MRI Findings

Grants

Funding Acknowledgements

J.B.F. has received fees as a board member, consultant, or lecturer from Boehringer Ingelheim, Lundbeck, Siemens, Syngis, and Synarc. C.G. has received fees as a consultant or lecture fees from Bayer Vital, Boehringer Ingelheim, EBS Technologies, Glaxo Smith Kline, Lundbeck, Pfizer, Sanofi Aventis, Silk Road Medical, and UCB. D.L. has received fees as a consultant for CoAxia and Concentric Medical, Inc. G.T. has received a research grant from the Else Kro-ner-Fresenius-Stiftung. T.T. has received a national grant from the French Government (PHRC). O.W. was supported in part by grants from the National Institutes of Health (R01NS059775, R01NS063925, P50NS051343) and received royalties and licensing fees from GE, Olea, and Imaging Biometrics.This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS). The PREdictive value of FLAIR and DWI for the identification of acute ischemic stroke patients <= 3 and <= 4.5 h of symptom onset-a multicenter study (PRE-FLAIR) has received funding from the Else-Kroner-Fresenius-Stiftung (2009_A36). In Berlin, data were collected within the 1000+ study, which has received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). This work was further supported by the European Union's Seventh Framework Programme grant agreement No. 202213 and No 223153 (European Stroke Network), the Volkswagen Foundation, and the Deutsche Forschungsgemeinschaft. Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) was a Phase II prospective, randomized, double-blinded, placebo-controlled, multinational trial funded by the National Health and Medical Research Council (Australia), the National Stroke Foundation (Australia), and the Heart Foundation of Australia. Valeur predictive des parametres IRM a la phase aigue de l'accident vasculaire cerebral: application a la gestion des essaistherapeutiques (VIRAGE) is a national multicentre study supported by French national grant "Le programme hospitalier de recherche Clinique" (PHRC).